FDA’s Fiscal Year 2027 Budget is Chock-Full of Legislative Proposals – Especially on Hatch-Waxman and the BPCIA By Kurt R. Karst —

FDA’s Fiscal Year 2027 Budget is Chock-Full of Legislative Proposals – Especially on Hatch-Waxman and the BPCIA By Kurt R. Karst — https://www.thefdalawblog.com/2026/04/fdas-fiscal-year-2027-budget-is-chock-full-of-legislative-proposals-especially-on-hatch-waxman-and-the-bpcia/?utm_source=rss&utm_medium=rss&utm_campaign=fdas-fiscal-year-2027-budget-is-chock-full-of-legislative-proposals-especially-on-hatch-waxman-and-the-bpcia Earlier this week, FDA released its Justification of Estimates for Appropriations Committees for the Agency’s Fiscal Year 2027 (“FY2027”) budget request. Prior budget requests included a separate document titled “FDA Legislative Proposals” (see, e.g., here, here, here, and here; and our prior post here). The FY2027 budget request incorporates them into the broader Justification of Estimates for Appropriations Committees document (Pages 16-27). But that’s not the only difference this year compared to prior years. For FY2027, FDA’s budget request includes a whopping 27(!!) legislative proposals. Here’s the run-down: